CHALFONT, PA – April 12, 2012 – Dr. Jay Lombard of Genomind, a company focused on neuropsychiatric personalized medicine, will speak to the challenges of diagnosing and treating brain disorders at the TEDMED 2012 Conference. The TEDMED 2012 Conference is held at The Kennedy Center in Washington, D.C., on April 10-13.
“I’m honored to be among the TEDMED featured speakers this year,” said Jay Lombard, DO, chief scientific and medical officer and co-founder of Genomind. Dr. Lombard will discuss the connection between our biological and conscious states as a pathway to discovering the origins of brain disorders that affect millions.
The diagnosis of neurological degenerative disorders such as Alzheimer’s, schizophrenia and autism remains a difficult clinical task. Unlike brain lesions such as a tumor or stroke, a specific mental state is inherently qualitative, dynamic and non-localized. While tests such as Magnetic Resonance Imaging (MRI) can reveal loss of brain tissue, there are no definitive diagnostic tests or biomarkers that can help distinguish these diseases reliably.
“While these diseases express emotionally, they originate in biology,” said Dr. Lombard. “I believe the pathway to diagnostic progress begins by understanding the connection between our emotional and molecular states.”
Dr. Lombard will also discuss the latest advances in genetics, proteomics, epigenetics and brain imaging, including biomarker development with the potential to provide clinicians with more specific diagnostic information on psychiatric disorders and treatment. The potential to discover the underlying disease process that occurs months or years before symptoms of mental illnesses appear will enable earlier diagnosis for patients, and allow clinicians to treat patients therapeutically, rather than symptomatically.
“I believe the sooner we move away from the paradigm that our brains and minds are separate entities and realize that they are interdependent and wholly integrated, the quicker we will find breakthroughs in psychiatric medicine,” said Dr. Lombard.
TEDMED is a community of prominent thought leaders around the world who come from every discipline within the fields of health and medicine, as well as from business, government, technology, academia, media and the arts. Each year, the community gathers at the annual TEDMED Conference to explore the challenges and opportunities facing health and medicine today and in the future. For more information, visit https://www.tedmed.com.
Genomind is a personalized medicine company, comprised of innovative researchers and expert leaders in psychiatry and neurology. Genomind is committed to discovery of the underlying causes of neuropsychiatric disorders and supports the development of personalized medicine that improves patients’ lives. Genomind was founded by Ronald I. Dozoretz, MD, a psychiatrist who has devoted his career to improving mental health. Jay Lombard, DO, a neurologist and co-founder of Genomind, is a critically acclaimed author and nationally recognized thought leader in neuropsychiatry practice and research.